Drug-Cosmetic Boundary Product Compliance Audit

This template is for boundary products that may be regulated as cosmetics or OTC drugs depending on their claims and presentation. It fits sunscreen and SPF products, anti-dandruff shampoos, medicated skincare, and similar SKUs where the label, active ingredient, and marketing language must align. It is not meant for general warehouse receiving or a pure quality control check. Use it when the compliance question is, "Does this product's presentation match its regulatory classification?"

Run it before launch, after any label or formula change, and whenever a new market or country version is introduced. It is also useful as a periodic shelf audit for active SKUs with frequent marketing updates, new badges, or revised carton artwork. If claims are managed by multiple teams, schedule it before artwork approval and again on final printed samples. That reduces the chance of a compliant formula being sold with a noncompliant presentation.

A quality, regulatory affairs, or compliance reviewer should own the audit, with support from packaging, marketing, and product development when needed. The person running it should be able to compare the approved formula, label copy, and market-specific requirements. For higher-risk SKUs, a second reviewer is helpful before release. The template works best when the auditor can document a deficiency and route it to the right owner for correction.

No. It is an inspection and evidence-capture tool that helps teams spot non-conformances before release or escalation. Legal or regulatory review may still be needed for borderline claims, new actives, or products sold in multiple jurisdictions. The template helps organize the facts: what was claimed, what was labeled, and what was actually present on the pack. That makes escalation faster and more consistent.

Common findings include SPF claims that overstate protection, drug-like claims on cosmetic packaging, missing or incomplete Drug Facts panels, and ingredient lists that do not match the approved formula. Auditors also catch before-and-after imagery, testimonials, or badges that imply treatment effects without support. Another frequent issue is inconsistent naming between the front panel, secondary panel, and outer carton. Those mismatches are often enough to trigger a non-conformance review.

It checks that SPF language stays within permitted sunscreen claims and does not drift into unsupported therapeutic promises. The auditor confirms that the product identity, active ingredient declaration, warnings, and directions match the approved sunscreen presentation for the market being reviewed. It also flags graphics or copy that imply broader drug effects than the label supports. That is important because sunscreen products often sit close to the cosmetic/drug boundary.

Yes. The scope section is designed to capture the market or country version being reviewed, so you can adapt the checklist to local labeling rules and claim restrictions. You can also add channel-specific checks for e-commerce pages, retail cartons, or marketplace listings if those are part of your release process. Many teams create separate versions for U.S. OTC, Canada, EU, or private-label retail packs. The core structure stays the same while the required statements change by market.

Treat it as a compliance deficiency and stop release until the discrepancy is resolved. Confirm whether the issue is a formula change, a labeling error, or a packaging mix-up across variants. Document the exact panel where the mismatch appears and attach photos so the corrective action owner can verify the fix. If the active ingredient, concentration, or claim set is wrong, escalate for regulatory review before the SKU moves forward.

An ad hoc check usually looks at one obvious issue, such as whether the Drug Facts panel is present. This template forces a structured review of scope, claims, required statements, ingredient consistency, and packaging cues in the order an inspector would actually see them. That makes it easier to spot boundary problems that are missed when teams review only one panel or only one claim. It also creates a repeatable record for audits and corrective actions.